Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
Fei Peng(Dalian Medical University), Qiang Liu(Sun Yat-sen University), Eric W.‐F. Lam(Ottawa Hospital), Jiao Xu(China National Center for Food Safety Risk Assessment), L-Z Xu(Dalian Medical University), Lei Zhang(Shanxi University), Ting Guo(Air Force Medical University), Li Lv(Second Affiliated Hospital of Dalian Medical University), J-J Xie(Dalian Medical University), Y-T Meng(Sun Yat-sen University), Yidan D. Zhao(Dalian Medical University), W-X Lin(Dalian Maternal and Child Health Hospital), X-F Liu(Dalian Medical University), T-T Li(Dalian Medical University), Fengmin An(Dalian Medical University), M-M Li(Sun Yat-sen University), H. F. Wang(Dalian Medical University), D-K Lv(Dalian Medical University), Bai Cui(Dalian Medical University)
Cited by 330
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Performance of high-loaded ANAMMOX UASB reactors containing granular sludge
|Water Research|2010|657
Anaerobic co-digestion of food waste and piggery wastewater: Focusing on the role of trace elements
|Bioresource Technology|2011|516
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434